294 related articles for article (PubMed ID: 29558871)
21. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
[TBL] [Abstract][Full Text] [Related]
22. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy.
Miklavcic D; Semrov D; Mekid H; Mir LM
Biochim Biophys Acta; 2000 Sep; 1523(1):73-83. PubMed ID: 11099860
[TBL] [Abstract][Full Text] [Related]
23. The improvement of irreversible electroporation therapy using saline-irrigated electrodes: a theoretical study.
Adeyanju OO; Al-Angari HM; Sahakian AV
Technol Cancer Res Treat; 2011 Aug; 10(4):347-60. PubMed ID: 21728392
[TBL] [Abstract][Full Text] [Related]
24. The importance of electric field distribution for effective in vivo electroporation of tissues.
Miklavcic D; Beravs K; Semrov D; Cemazar M; Demsar F; Sersa G
Biophys J; 1998 May; 74(5):2152-8. PubMed ID: 9591642
[TBL] [Abstract][Full Text] [Related]
25. Parametric optimization of electric field strength for cancer electrochemotherapy on a chip-based model.
Zhao D; Wu M; Huang D; Liang Z; Wei Z; Li Z
Theranostics; 2018; 8(2):358-368. PubMed ID: 29290813
[TBL] [Abstract][Full Text] [Related]
26. An e-learning application on electrochemotherapy.
Corovic S; Bester J; Miklavcic D
Biomed Eng Online; 2009 Oct; 8():26. PubMed ID: 19843322
[TBL] [Abstract][Full Text] [Related]
27. Modeling of electric field distribution in tissues during electroporation.
Corovic S; Lackovic I; Sustaric P; Sustar T; Rodic T; Miklavcic D
Biomed Eng Online; 2013 Feb; 12():16. PubMed ID: 23433433
[TBL] [Abstract][Full Text] [Related]
28. ESOPE-Equivalent Pulsing Protocols for Calcium Electroporation: An In Vitro Optimization Study on 2 Cancer Cell Models.
Romeo S; Sannino A; Scarfì MR; Vernier PT; Cadossi R; Gehl J; Zeni O
Technol Cancer Res Treat; 2018 Jan; 17():1533033818788072. PubMed ID: 30021498
[TBL] [Abstract][Full Text] [Related]
29. On-chip testing device for electrochemotherapeutic effects on human breast cells.
Choi YS; Kim HB; Kwon GS; Park JK
Biomed Microdevices; 2009 Feb; 11(1):151-9. PubMed ID: 18791868
[TBL] [Abstract][Full Text] [Related]
30. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
[TBL] [Abstract][Full Text] [Related]
31. The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma.
Adeyanju OO; Al-Angari HM; Sahakian AV
Radiol Oncol; 2012 Jun; 46(2):126-35. PubMed ID: 23077449
[TBL] [Abstract][Full Text] [Related]
32. Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation.
Zupanic A; Kos B; Miklavcic D
Phys Med Biol; 2012 Sep; 57(17):5425-40. PubMed ID: 22864181
[TBL] [Abstract][Full Text] [Related]
33. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue.
Garcia PA; Davalos RV; Miklavcic D
PLoS One; 2014; 9(8):e103083. PubMed ID: 25115970
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization.
Sel D; Lebar AM; Miklavcic D
IEEE Trans Biomed Eng; 2007 May; 54(5):773-81. PubMed ID: 17518273
[TBL] [Abstract][Full Text] [Related]
35. Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls.
Pavliha D; Kos B; Zupanič A; Marčan M; Serša G; Miklavčič D
Bioelectrochemistry; 2012 Oct; 87():265-73. PubMed ID: 22341626
[TBL] [Abstract][Full Text] [Related]
36. Numerical model of dog mast cell tumor treated by electrochemotherapy.
Suzuki DO; Anselmo J; de Oliveira KD; Freytag JO; Rangel MM; Marques JL; Ramos A
Artif Organs; 2015 Feb; 39(2):192-7. PubMed ID: 25041415
[TBL] [Abstract][Full Text] [Related]
37. Microdevice for analyzing the effect of electrochemotherapy on cancer cells.
Choi YS; Kim HB; Kim SH; Choi J; Park JK
Anal Chem; 2009 May; 81(9):3517-22. PubMed ID: 19344145
[TBL] [Abstract][Full Text] [Related]
38. Oral Mucosa Model for Electrochemotherapy Treatment of Dog Mouth Cancer: Ex Vivo, In Silico, and In Vivo Experiments.
Suzuki DOH; Berkenbrock JA; Frederico MJS; Silva FRMB; Rangel MMM
Artif Organs; 2018 Mar; 42(3):297-304. PubMed ID: 29027689
[TBL] [Abstract][Full Text] [Related]
39. Single-needle electroporation and interstitial electrochemotherapy: in vivo safety and efficacy evaluation of a new system.
Pedersoli F; Ritter A; Zimmermann M; Schulze-Hagen M; Liebl M; Dethlefsen E; von Stillfried S; Pfeffer J; Kuhl CK; Bruners P; Isfort P
Eur Radiol; 2019 Nov; 29(11):6300-6308. PubMed ID: 31101968
[TBL] [Abstract][Full Text] [Related]
40. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).
Kos B; Voigt P; Miklavcic D; Moche M
Radiol Oncol; 2015 Sep; 49(3):234-41. PubMed ID: 26401128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
